6lcb: Difference between revisions

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-'''Unreleased structure'''
-The entry 6lcb is ON HOLD
+==Crystal structure of human Dishevelled1 PDZ domain with its inhibitor NPL3009==
+<StructureSection load='6lcb' size='340' side='right'caption='[[6lcb]], [[Resolution|resolution]] 1.40&Aring;' scene=''>
-Authors: Yasukochi, S., Numoto, N., Tenno, N., Tenno, T., Ito, N., Hiroaki, H.
+== Structural highlights ==
+<table><tr><td colspan='2'>[[6lcb]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6LCB OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6LCB FirstGlance]. <br>
-Description: Crystal structure of human Dishevelled1 PDZ domain with its inhibitor NPL3009
+</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.4&#8491;</td></tr>
-[[Category: Unreleased Structures]]
+<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=E83:2-[[3-[(2E)-2-[1,3-bis(oxidanylidene)-1-phenyl-butan-2-ylidene]hydrazinyl]phenyl]sulfonylamino]benzoic+acid'>E83</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
-[[Category: Hiroaki, H]]
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6lcb FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6lcb OCA], [https://pdbe.org/6lcb PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6lcb RCSB], [https://www.ebi.ac.uk/pdbsum/6lcb PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6lcb ProSAT]</span></td></tr>
-[[Category: Tenno, N]]
+</table>
-[[Category: Numoto, N]]
+== Disease ==
-[[Category: Tenno, T]]
+[https://www.uniprot.org/uniprot/DVL1_HUMAN DVL1_HUMAN] Autosomal dominant Robinow syndrome. The disease is caused by variants affecting the gene represented in this entry.
-[[Category: Ito, N]]
+== Function ==
-[[Category: Yasukochi, S]]
+[https://www.uniprot.org/uniprot/DVL1_HUMAN DVL1_HUMAN] Participates in Wnt signaling by binding to the cytoplasmic C-terminus of frizzled family members and transducing the Wnt signal to down-stream effectors. Plays a role both in canonical and non-canonical Wnt signaling. Plays a role in the signal transduction pathways mediated by multiple Wnt genes. Required for LEF1 activation upon WNT1 and WNT3A signaling. DVL1 and PAK1 form a ternary complex with MUSK which is important for MUSK-dependent regulation of AChR clustering during the formation of the neuromuscular junction (NMJ).
+__TOC__
+</StructureSection>
+[[Category: Homo sapiens]]
+[[Category: Large Structures]]
+[[Category: Hiroaki H]]
+[[Category: Ito N]]
+[[Category: Numoto N]]
+[[Category: Tenno N]]
+[[Category: Tenno T]]
+[[Category: Yasukochi S]]